SKI complex loss renders 9p21.3-deleted or MSI-H cancers dependent on PELO.

Saved in:
Bibliographic Details
Title: SKI complex loss renders 9p21.3-deleted or MSI-H cancers dependent on PELO.
Authors: Borck PC; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Boyle I; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Jankovic K; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA., Bick N; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Foster K; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Lau AC; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Parker-Burns LI; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA., Lubicki DA; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Li T; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA., Borah AA; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Lofaso NJ; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA., Das Sharma S; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA., Chan T; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA., Kishen RV; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA., Adeagbo A; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Raghavan S; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Aquilanti E; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Division of Neuro-Oncology, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Prensner JR; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Pediatrics and Biological Chemistry, Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA., Krill-Burger JM; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Golub TR; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Pediatric Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Campbell CD; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Dempster JM; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Chan EM; Broad Institute of MIT and Harvard, Cambridge, MA, USA. emc2291@cumc.columbia.edu.; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA. emc2291@cumc.columbia.edu.; Department of Medicine, Division of Hematology/Oncology, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA. emc2291@cumc.columbia.edu.; New York Genome Center, New York, NY, USA. emc2291@cumc.columbia.edu., Vazquez F; Broad Institute of MIT and Harvard, Cambridge, MA, USA. vazquez@broadinstitute.org.
Source: Nature [Nature] 2025 Feb; Vol. 638 (8052), pp. 1104-1111. Date of Electronic Publication: 2025 Feb 05.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-4687
DOI:10.1038/s41586-024-08509-3